Approval · Notice of Compliance 31341 · 2023
ILUMYA: Notice of Compliance 31341
Issued July 28, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31341
- Date
- July 28, 2023
- Company
- Sun Pharmaceutical Industries LimitedMumbai, Maharashtra, India
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ILUMYA | Not yet assigned | — |
Medicinal ingredients
- TILDRAKIZUMAB 100 MG per ML